Isoflurane intravenous - Yichang Humanwell PharmaceuticalAlternative Names: emulsified isoflurane - Yichang Humanwell Pharmaceutical
Latest Information Update: 16 Feb 2016
At a glance
- Originator Yichang Humanwell Pharmaceutical
- Class General anaesthetics
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Anaesthesia
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 15 Feb 2016 Phase-I clinical trials in Anaesthesia (In volunteers) in China (IV)